The U.S. Food and Drug Administration has scheduled a meeting of its Vaccines and Related Biological Products Advisory Committee (VRBPAC) on Feb. 26 to discuss the request for emergency use authorization (EUA) of a COVID-19 vaccine from Janssen Biotech Inc.
#COVID19 #VRBPAC
Captions are available here:
